NCT02914470View on ClinicalTrials.gov

Carboplatin-cyclophosphamide Combined With Atezolizumab

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

October 31, 2021

Conditions
Breast CancerCervix CancerOvarian CancerEndometrial Cancer
Interventions
DRUG

carbplatin, cyclophophamide, atezolizumab

Trial Locations (1)

Unknown

Antoni van Leeuwenhoek, Amsterdam

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

The Netherlands Cancer Institute

OTHER

NCT02914470 - Carboplatin-cyclophosphamide Combined With Atezolizumab | Biotech Hunter | Biotech Hunter